STOCKWATCH
·
Medical Specialities
Quarterly ResultMay 5, 2026, 01:21 PM

Henry Schein Q1 Net Sales $3.37B, Diluted EPS $0.92

AI Summary

Henry Schein Inc. reported increased net sales of $3,368 million for the first quarter of 2026, up from $3,168 million in the prior year, with diluted EPS rising to $0.92 from $0.88. However, net income attributable to the company slightly decreased to $107 million from $110 million. The company also engaged in business acquisitions totaling $93 million and repurchased $125 million of common stock, while net cash used in operating activities was $(97) million.

Key Highlights

  • Net sales for Q1 2026 increased to $3,368 million from $3,168 million in Q1 2025.
  • Diluted earnings per share rose to $0.92 in Q1 2026 from $0.88 in Q1 2025.
  • Net income attributable to Henry Schein, Inc. was $107 million, down from $110 million.
  • Operating income for Q1 2026 increased to $182 million from $175 million.
  • Global Distribution and Value-Added Services net sales were $2,836 million.
  • Global Specialty Products net sales were $359 million.
  • Net cash used in operating activities was $(97) million for Q1 2026.
  • The company repurchased $125 million of common stock in Q1 2026.
  • Acquired companies for $93 million in Q1 2026, recognizing an $11 million gain.
HSIC
Medical Specialities
HENRY SCHEIN INC

Price Impact